AAAAAA
Results:
1-9
|
Results: 9
Authors:
CROOK JM
BUNTING PS
Citation: Jm. Crook et Ps. Bunting, PERCENT FREE PROSTATE-SPECIFIC ANTIGEN AFTER RADIOTHERAPY FOR PROSTATE-CANCER, Urology, 52(1), 1998, pp. 100-105
Authors:
BUNTING PS
CHONG N
HOLOWATY EJ
GOEL V
Citation: Ps. Bunting et al., PROSTATE-SPECIFIC ANTIGEN UTILIZATION IN ONTARIO - EXTENT OF TESTING IN PATIENTS WITH AND WITHOUT CANCER, Clinical biochemistry, 31(6), 1998, pp. 501-511
Authors:
BUNTING PS
MIYAZAKI JH
GOEL W
Citation: Ps. Bunting et al., LABORATORY SURVEY OF PROSTATE-SPECIFIC ANTIGEN TESTING IN ONTARIO, Clinical biochemistry, 31(1), 1998, pp. 47-49
Authors:
ALLEN LC
BUNTING PS
Citation: Lc. Allen et Ps. Bunting, POSTDOCTORAL TRAINING IN CLINICAL-CHEMISTRY - LABORATORY TRAINING ASPECTS, Clinical biochemistry, 28(5), 1995, pp. 481-497
Authors:
BUNTING PS
Citation: Ps. Bunting, A GUIDE TO THE INTERPRETATION OF SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS, Clinical biochemistry, 28(3), 1995, pp. 221-241
Authors:
FAM AG
MORAVAPROTZNER I
PURCELL C
YOUNG BD
BUNTING PS
LEWIS AJ
Citation: Ag. Fam et al., ACCELERATION OF EXPERIMENTAL LAPINE OSTEOARTHRITIS BY CALCIUM PYROPHOSPHATE MICROCRYSTALLINE SYNOVITIS, Arthritis and rheumatism, 38(2), 1995, pp. 201-210
Authors:
MOORE MJ
ERLICHMAN C
THIESSEN JJ
BUNTING PS
HARDY R
KERR I
SOLDIN S
Citation: Mj. Moore et al., VARIABILITY IN THE PHARMACOKINETICS OF CYCLOPHOSPHAMIDE, METHOTREXATEAND 5-FLUOROURACIL IN WOMEN RECEIVING ADJUVANT TREATMENT FOR BREAST-CANCER, Cancer chemotherapy and pharmacology, 33(6), 1994, pp. 472-476
Authors:
ANGELOPOULOU K
DIAMANDIS EP
SUTHERLAND DJA
KELLEN JA
BUNTING PS
Citation: K. Angelopoulou et al., PREVALENCE OF SERUM ANTIBODIES AGAINST THE P53 TUMOR-SUPPRESSOR GENE PROTEIN IN VARIOUS CANCERS, International journal of cancer, 58(4), 1994, pp. 480-487
Authors:
BUNTING PS
GOLDBERG DM
Citation: Ps. Bunting et Dm. Goldberg, EDUCATION IN CLINICAL BIOCHEMISTRY - THE CANADIAN SCENE, Clinica chimica acta, 232(1-2), 1994, pp. 63-84
Risultati:
1-9
|